Discover
TMO
Thermo Fisher Scientific Inc.
513.33
120 x 511.98
40 x 522.00
bid
ask
+
11.97
2.39%
80 @ 07:13 AM
511.98 -1.35 (0.26%)
| Ytd | -11.41% | |
| 1y | 20.00% |
502.87
day range
521.17
403.36
52 week range
643.99
| Open | 504.78 | Prev Close | 501.36 | Low | 502.87 | High | 521.17 | Mkt Cap | 190.76B |
| Vol | 1.63M | Avg Vol | 2.32M | EPS | 18.17 | P/E | 28.25 | Forward P/E | 18.84 |
| Beta | 0.87 | Short Ratio | 1.82 | Inst. Own | 93.99% | Dividend | 1.88 | Div Yield | 0.37 |
| Ex Div Date | 06-15 | Earning | 07-23 | 50-d Avg | 473.42 | 200-d Avg | 526.23 | 1yr Est | 596.26 |
| Income Statement | |||
| Total Revenue | 11.01B | ||
| Revenues (USD) | 11.01B | ||
| Cost of Revenue | 6.58B | ||
| Gross Profit | 4.43B | ||
| Operating Expenses | 2.57B | ||
| Research and Development Expense | 336.00M | ||
| Selling, General and Administrative Expense | 2.18B | ||
| Operating Income | 1.86B | ||
| Interest Expense | 354.00M | ||
| Income Tax Expense | 70.00M | ||
| Net Income | 1.65B | ||
| Net Income Common Stock | 1.65B | ||
| Net Income Common Stock (USD) | 1.65B | ||
| Consolidated Income | 1.66B | ||
| Net Income to Non-Controlling Interests | 5.00M | ||
| Earnings per Basic Share | 4.44 | ||
| Earnings per Basic Share (USD) | 4.44 | ||
| Earnings per Diluted Share | 4.43 | ||
| Dividends per Basic Common Share | 0.47 | ||
| Earning Before Interest & Taxes (EBIT) | 2.08B | ||
| Earning Before Interest & Taxes (USD) | 2.08B | ||
| Weighted Average Shares | 372.00M | ||
| Weighted Average Shares Diluted | 373.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.25B | ||
| Cash and Equivalents (USD) | 3.25B | ||
| Investments | 2.00M | ||
| Investments Current | 2.00M | ||
| Trade and Non-Trade Receivables | 9.20B | ||
| Current Assets | 22.32B | ||
| Property, Plant & Equipment Net | 10.66B | ||
| Total Assets | 113.28B | ||
| Debt Current | 3.09B | ||
| Total Debt | 43.16B | ||
| Current Liabilities | 14.62B | ||
| Debt Non-Current | 40.07B | ||
| Total Liabilities | 61.34B | ||
| Accumulated Retained Earnings (Deficit) | 60.63B | ||
| Accumulated Other Comprehensive Income | -2.50B | ||
| Shareholders Equity | 51.93B | ||
| Shareholders Equity (USD) | 51.93B | ||
| Assets Non-Current | 90.97B | ||
| Total Debt (USD) | 43.16B | ||
| Deferred Revenue | 2.93B | ||
| Goodwill and Intangible Assets | 74.33B | ||
| Inventory | 5.50B | ||
| Liabilities Non-Current | 46.72B | ||
| Trade and Non-Trade Payables | 3.34B | ||
| Tax Liabilities | 2.11B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 736.00M | ||
| Net Cash Flow from Financing | 1.09B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.60B | ||
| Capital Expenditure | -367.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -8.87B | ||
| Issuance (Purchase) of Equity Shares | -3.00B | ||
| Issuance (Repayment) of Debt Securities | 4.22B | ||
| Payment of Dividends & Other Cash Distributions | -162.00M | ||
| Net Cash Flow from Investing | -8.96B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 236.00M | ||
| Net Cash Flow from Operations | 1.19B | ||
| Effect of Exchange Rate Changes on Cash | 78.00M | ||
| Share Based Compensation | 83.00M | ||